Journal Browser

Go Edit a Special Issue

Archive

Special Issue Title:

Selected papers from Korean Society of Emergency Medicine (KSEM) in 2021-2022

Deadline for manuscript submissions: 31 December 2022

Print Special Issue Flyer (31)

Special Issue Editor

  • Guest Editor

    Kyungwon Lee, MD, PhDE-MailWebsite

    Associate professor, Uijeongbu Eulji Medical Center, Eulji University Department of Emergency Medicine, Daejeon, South Korea; Chairman of the board, the Korean Association of EMS Physicians (KAEMSP); Chairman, External Cooperation Committee, the Korean Society of Emergency Medicine (KSEM)

    Interests: Emergency medicine

  • Guest Editor

    Young Duck Cho, MD, PhDE-MailWebsite

    Associate Professor, Korea University, School of Medicine, Korea University Guro Regional Emergency Center, Seoul, South Korea; Chairman of the International Relations Committee of the Korean Society of Emergency Medicine

    Interests: Emergency medicine

Special Issue Information

Since the Korean Society of Emergency Medicine (KSEM) was established in 1989, it has been striving to provide the best emergency medical services to its members by focusing on emergency patient care, emergency medical care, and disaster system to protect the health and safety of its people. Therefore, many people are working hard to make the Korean Society of Emergency Medicine always awake, prepare for the future, study steadily, and become members of society.


KSEM is excited to be a part of Signa Vitae journal. We hope articles from our society’s prestigious members would contribute to a special edition in 2021-2022.


Thank you for sharing such a great experience with us.


The Chair of International affairs

Korean Society of Emergency Medicine

Keywords

Emergency medicine

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (6 papers)

Open Access Special Issue

Impact of indemnity private health insurance on emergency department visits and expenditures

Jeong Wan Kwak,Yu Jin Chung,Hye Sun Lee,Soyoung Jeon,Je Sung You,Hyun Soo Chung,Sung Phil Chung

DOI: 10.22514/sv.2023.077

(This article belongs to the Special Issue Selected papers from Korean Society of Emergency Medicine (KSEM) in 2021-2022 )

Abstract ( 2062 ) PDF (2.2 MB) ( 174 ) Full Text

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.3 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences